High Antimicrobial Resistance in ESKAPE Pathogens at a Rwandan Tertiary Hospital

Antimicrobial resistance (AMR) is a global health threat, increasing morbidity, mortality, and healthcare costs. Multi-drug resistant ESKAPE pathogens (<i>Enterococcus faecium</i>, <i>Staphylococcus aureus</i>, <i>Klebsiella pneumoniae</i>, <i>Acinetobacter baumannii</i>, <i>Pseudomonas aeruginosa</i>, and <i>Enterobacter cloacae</i>) cause most hospital-acquired infections. Local data on their resistance profiles remain limited in low-income settings. This study assessed the prevalence and resistance patterns of ESKAPE pathogens isolated from clinical specimens at Rwanda Military Referral and Teaching Hospital. A descriptive cross-sectional study was conducted from June 2022 to January 2023. ESKAPE isolates were identified and tested for antimicrobial susceptibility using the BD Phoenix M50 System. Data on sample type, ward, and demographics were analyzed. Of 744 bacterial findings, 207 (30%) were ESKAPE isolates. After excluding duplicates and non-recovered isolates, 156 were identified as ESKAPE. <i>K. pneumoniae</i> was most common (41%), followed by <i>S. aureus</i> (27%), <i>A. baumannii</i> (13%), <i>P. aeruginosa</i> (11%), and <i>E. cloacae</i> (8%); no <i>E. faecium</i> was detected. Among Gram-negatives, 63% were resistant to third-generation cephalosporins and 32% to carbapenems, with <i>A. baumannii</i> showing highest resistance (85% and 75%). Methicillin-Resistance in <i>Staphylococcus aureus</i> (MRSA) was 7%. This first hospital-based study in Rwanda shows high cephalosporin and carbapenem resistance, highlighting the need to strengthen diagnostics and stewardship.